Skip to main navigation

About
Pipeline
Clinical Trials
Partners
News
Investors
Contact
Community

PRESS RELEASES

Webcast

H.C. Wainwright Global Investment Conference

05/24/22 7:00 AM EDT

Keyword Search

Year:

09/02/21

Summary Toggle
TRACON Pharmaceuticals to Present at the Wells Fargo Virtual Healthcare Conference

Printer Friendly

PDF Version
08/11/21

Summary Toggle
TRACON Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Printer Friendly

PDF Version
08/09/21

Summary Toggle
TRACON Pharmaceuticals Announces Results of Second Independent Data Monitoring Committee Review of Safety Data from ENVASARC Pivotal Trial

Printer Friendly

PDF Version
08/03/21

Summary Toggle
TRACON Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference

Printer Friendly

PDF Version
07/28/21

Summary Toggle
TRACON to Report Second Quarter 2021 Financial Results and Company Highlights on August 11, 2021

Printer Friendly

PDF Version
07/21/21

Summary Toggle
TRACON Pharmaceuticals Increases Previously Announced Bought Deal Offering of Common Stock to $15.0 Million

Printer Friendly

PDF Version
07/21/21

Summary Toggle
TRACON Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock

Printer Friendly

PDF Version
07/20/21

Summary Toggle
TRACON Pharmaceuticals Announces Appointment of Brenda Marczi, PharmD, as Senior Vice President, Regulatory Affairs, and Granting of Inducement Award

Printer Friendly

PDF Version
06/30/21

Summary Toggle
TRACON Pharmaceuticals Announces Appointment of Ya Huang as Executive Director of Statistical Programming and Granting of Inducement Award

Printer Friendly

PDF Version
06/29/21

Summary Toggle
TRACON Pharmaceuticals Announces Orphan Drug Designation for Envafolimab in Soft Tissue Sarcoma

Printer Friendly

PDF Version

Pagination

First page
Previous page
…
Page 2
Current page 3
Page 4
Page 5
…
Next page
Last page

Print Page
RSS Feeds
Email Alerts
Contact

4350 La Jolla Village Drive
Suite 800
San Diego, CA 92122

Phone: (858) 550-0780
Fax: (858) 550-0786
Email: info@traconpharma.com

About

Management
Board of Directors
Scientific Advisory Board

News

Press Releases
Publications

Pipeline

Envafolimab (KN035)
TRC102
TRC253

Partners

Contact

Clinical Trials

Investors

Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
- Historical Price Lookup
- Investment Calculator
Investor FAQ
Contact

Copyright © TRACON Pharmaceuticals, Inc. 2022